AI can predict chemotherapy effectiveness

The new AI algorithm, part of the open-source Cancer-Net initiative led by Dr. Alexander Wong, could help unsuitable candidates avoid the serious side effects of chemotherapy and pave the way for better surgical outcomes for those who are suitable.

“An AI system that can help predict if a patient is likely to respond well to a given treatment gives doctors the tool needed to prescribe the best personalised treatment for a patient to improve recovery and survival,” said Wong, a professor of systems design engineering at the University of Waterloo.

In a project led by Amy Tai, a graduate student with the Vision and Image Processing (VIP) Lab, the AI software was trained with images of breast cancer made with a new magnetic image resonance modality, invented by Wong and his team, called synthetic correlated diffusion imaging (CDI).

According to researchers, knowledge gleaned from CDI images of old breast cancer cases and information on their outcomes allows the AI to predict if pre-operative chemotherapy treatment would benefit new patients based on their CDI images.

MORE IN MEDICAL AND HEALTHCARE

Known as neoadjuvant chemotherapy, the pre-surgical treatment can shrink tumours to make surgery possible or easier and reduce the need for major surgery such as mastectomies.

"I'm quite optimistic about this technology as deep-learning AI has the potential to see and discover patterns that relate to whether a patient will benefit from a given treatment," said Wong, a director of the VIP Lab and the Canada Research Chair in Artificial Intelligence and Medical Imaging.

A paper on the project was recently presented at Med-NeurIPS as part of NeurIPS 2022, an international AI conference.

The new AI algorithm and complete dataset of CDI images of breast cancer have been made publicly available through the Cancer-Net initiative so other researchers can help advance the field.